153 related articles for article (PubMed ID: 8685460)
1. [Scintigraphic characterization of expansive lesions located in the adrenals. Comparison with magnetic resonance imaging].
Maurea S; Klain M; Lastoria S; Caracò C; Castelli L; Varrella P; Filice S; Rossi R; Salvatore M
Radiol Med; 1995 Dec; 90(6):756-65. PubMed ID: 8685460
[TBL] [Abstract][Full Text] [Related]
2. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy.
Quint LE; Glazer GM; Francis IR; Shapiro B; Chenevert TL
Radiology; 1987 Oct; 165(1):89-93. PubMed ID: 3628794
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
6. [A comparison of scintigraphy with radioiodinated MIBG and CT in localizing pheochromocytomas].
Rufini V; Troncone L; Valentini AL; Danza FM
Radiol Med; 1988 Nov; 76(5):466-70. PubMed ID: 3205923
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
[TBL] [Abstract][Full Text] [Related]
8. MR imaging of the adrenal gland in Sipple disease.
Mathieu E; Despres E; Delepine N; Taieb A
J Comput Assist Tomogr; 1987; 11(5):790-4. PubMed ID: 2888797
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Maurea S; Klain M; Mainolfi C; Ziviello M; Salvatore M
J Nucl Med; 2001 Jun; 42(6):884-92. PubMed ID: 11390552
[TBL] [Abstract][Full Text] [Related]
10. Adrenal masses: quantification of fat content with double-echo chemical shift in-phase and opposed-phase FLASH MR images for differentiation of adrenal adenomas.
Namimoto T; Yamashita Y; Mitsuzaki K; Nakayama Y; Makita O; Kadota M; Takahashi M
Radiology; 2001 Mar; 218(3):642-6. PubMed ID: 11230633
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
Maurea S; Cuocolo A; Reynolds JC; Neumann RD; Salvatore M
Q J Nucl Med; 1996 Dec; 40(4):365-71. PubMed ID: 9050342
[TBL] [Abstract][Full Text] [Related]
13. Adrenal imaging with 131I-19-iodocholesterol in the diagnostic evaluation of patients with aldosteronism.
Seabold JE; Cohen EL; Beierwaltes WH; Hinerman DL; Nishiyama RH; Bookstein JJ; Ice RD; Balachandran S
J Clin Endocrinol Metab; 1976 Jan; 42(1):41-51. PubMed ID: 1249193
[TBL] [Abstract][Full Text] [Related]
14. Quantitative imaging characterization of hypersecreting or nonhypersecreting adrenal adenomas: comparison between iodine-131 norcholesterol uptake and magnetic resonance signal intensity ratios.
Maurea S; Imbriaco M; Mollica C; Pace L; Salvatore M
Nucl Med Commun; 2011 Jun; 32(6):535-41. PubMed ID: 21448089
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear medicine methods for the diagnosis of adrenal tumors].
Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
[TBL] [Abstract][Full Text] [Related]
16. Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation.
Velchik MG; Alavi A; Kressel HY; Engelman K
J Nucl Med; 1989 Mar; 30(3):328-36. PubMed ID: 2738662
[TBL] [Abstract][Full Text] [Related]
17. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
[TBL] [Abstract][Full Text] [Related]
18. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
19. MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.
van Gils AP; Falke TH; van Erkel AR; Arndt JW; Sandler MP; van der Mey AG; Hoogma RP
Radiographics; 1991 Jan; 11(1):37-57. PubMed ID: 1671719
[TBL] [Abstract][Full Text] [Related]
20. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
